152 related articles for article (PubMed ID: 6300372)
1. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
[TBL] [Abstract][Full Text] [Related]
2. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
Durham S; Vore M
J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
[TBL] [Abstract][Full Text] [Related]
3. Biliary excretion of estradiol-17 beta-glucuronide in the rat.
Takikawa H; Yamazaki R; Sano N; Yamanaka M
Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.
Huang L; Hoffman T; Vore M
Hepatology; 1998 Nov; 28(5):1371-7. PubMed ID: 9794924
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
Meyers M; Slikker W; Pascoe G; Vore M
J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
[TBL] [Abstract][Full Text] [Related]
6. Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide.
Gerk PM; Li W; Vore M
Drug Metab Dispos; 2004 Oct; 32(10):1139-45. PubMed ID: 15280218
[TBL] [Abstract][Full Text] [Related]
7. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
[TBL] [Abstract][Full Text] [Related]
8. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Liu Y; Huang L; Hoffman T; Gosland M; Vore M
Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
[TBL] [Abstract][Full Text] [Related]
9. The effect of pregnancy and treatment with 17 beta-estradiol on the transport of organic anions into isolated rat hepatocytes.
Brock WJ; Vore M
Drug Metab Dispos; 1984; 12(6):713-6. PubMed ID: 6150820
[TBL] [Abstract][Full Text] [Related]
10. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat.
Meyers M; Slikker W; Vore M
J Pharmacol Exp Ther; 1981 Jul; 218(1):63-73. PubMed ID: 7241390
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes. Lack of correlation between cholestasis and inhibition of taurocholate uptake.
Brock WJ; Durham S; Vore M
J Steroid Biochem; 1984 May; 20(5):1181-5. PubMed ID: 6727367
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
13. Binding of 3H-estradiol-17 beta-(beta-D-glucuronide), a cholestatic organic anion, to rat liver plasma membranes. Evidence consonant with identification of organic anion carriers.
Takacs AL; Vore M
Mol Pharmacol; 1987 Oct; 32(4):511-8. PubMed ID: 3670282
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of isotretinoin. Biliary excretion of isotretinoin glucuronide in the rat.
Meloche S; Besner JG
Drug Metab Dispos; 1986; 14(2):246-9. PubMed ID: 2870901
[TBL] [Abstract][Full Text] [Related]
16. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis.
Mottino AD; Veggi LM; Wood M; Román JM; Vore M
J Pharmacol Exp Ther; 2003 Oct; 307(1):306-13. PubMed ID: 12893835
[TBL] [Abstract][Full Text] [Related]
17. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
Accatino L; Pizarro M; Solís N; Koenig CS
Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
[TBL] [Abstract][Full Text] [Related]
18. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
Gosland M; Tsuboi C; Hoffman T; Goodin S; Vore M
Cancer Res; 1993 Nov; 53(22):5382-5. PubMed ID: 8106146
[TBL] [Abstract][Full Text] [Related]
19. Characterization of [3H]estradiol-17 beta-(beta-D-glucuronide) binding sites in basolateral and canalicular liver plasma membranes.
Changchit A; Durham S; Vore M
Biochem Pharmacol; 1990 Sep; 40(6):1219-25. PubMed ID: 2169743
[TBL] [Abstract][Full Text] [Related]
20. ATP-dependent transport of beta-estradiol 17-(beta-D-glucuronide) in rat canalicular membrane vesicles.
Vore M; Hoffman T; Gosland M
Am J Physiol; 1996 Nov; 271(5 Pt 1):G791-8. PubMed ID: 8944692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
